Related Resources

Eliza Maciag

Eliza Maciag is a senior manager on PhRMA’s Public Affairs team, focusing on 340B, PBMs and the cost and value of medicines. Prior to joining PhRMA, she worked in the Strategic Communications department at the Investment Company Institute, where she led rapid response initiatives and grassroots campaigns. Eliza holds a bachelor’s degree in political science from Trinity College (CT) and a master’s degree from the Graduate School of Political Management at George Washington University. 

Originally from Connecticut, Eliza is based in Washington, D.C. Outside of work, she enjoys golfing, biking, skiing and swapping book recommendations.

ICYMI: Hospital consolidation is driving up health care costs

August 27, 2026

Insurers blame GLP-1s for rising costs. The data tells a different story.

August 14, 2026

The FTC’s PBM enforcement actions gave us a glimpse behind the curtain; it’s time to let the light in.

August 7, 2026

ICYMI: Fox business hosts call 340B a ‘Rotten System’ and ‘Cash Cow’ for hospitals

July 23, 2026

340B’s lack of guardrails lets big hospital systems turn it into an oversight-free revenue stream

June 22, 2026

Hospitals in the hot seat: Congress sharpens focus on 340B, consolidation and rising costs

May 7, 2026

A program off track: How 340B drives both hospital consolidation and system gaming

April 27, 2026

340B hospitals buy low and sell high, a new analysis shows

March 12, 2026

Separating fact from fiction in the medicine supply chain

February 11, 2026

Data shows tax-exempt hospital profit-seeking behavior, not drug prices, is driving explosive 340B expansion

January 8, 2026